The Latest Breaking News from REPL

Here's Why Replimune Group (REPL) Stock Is Up Over 100% Today

Shares of Replimune Group, Inc. (NASDAQ:REPL) are rising Monday after the clinical stage biotechnology company shared an important regulatory update.

Benzinga · Oct 20, 2025

WW International, Replimune Group, Datavault AI, GRAIL And Other Big Stocks Moving Higher On Monday

U.S. stocks were higher, with the Nasdaq Composite gaining more than 1% on Monday.

Benzinga · Oct 20, 2025

Why Is Replimune Stock Trading Lower On Monday?

On Monday, Replimune Group Inc. (NASDAQ:REPL) is reeling after the FDA unexpectedly rejected its skin cancer treatment, triggering a stock plunge and a wave of investor outrage.

Benzinga · Aug 4, 2025